Circassia Pharmaceuticals Plc Director/PDMR Shareholding (3495O)
01 October 2019 - 8:25PM
UK Regulatory
TIDMCIR
RNS Number : 3495O
Circassia Pharmaceuticals Plc
01 October 2019
Director/PDMR Shareholding
Oxford, UK - 1 October 2019: Circassia Pharmaceuticals plc
("Circassia" or "the Company"; LSE: CIR), a specialty
biopharmaceutical company focused on respiratory disease, today
announces that on 30 September 2019, Jonathan Emms, Chief Operating
Officer of Circassia, purchased 300,000 Ordinary Shares on the
London Stock Exchange at a price of 16.5 pence per share.
Contacts
Circassia Tel: +44 (0)1865
Steve Harris, Chief Executive Officer 405560
Julien Cotta, Chief Financial Officer
Rob Budge, Corporate Communications
Peel Hunt (Nominated Adviser and Joint Tel: +44 (0) 20
Broker) 7418 8900
James Steel / Dr Christopher Golden
finnCap (Joint Broker) Tel: +44 (0) 20
Geoff Nash / Alice Lane 7220 0500
Numis Securities (Joint Broker) Tel: +44 (0) 20
James Black / Freddie Barnfield 7260 1000
FTI Consulting Tel: +44 (0) 20
Simon Conway / Ciara Martin 3727 1000
Notification and public disclosure of transactions by persons
discharging managerial responsibilities and persons closely
associated with them
1. Details of the person discharging managerial responsibilities
/ person closely associated
a. Name Jonathan Emms
=============================== ===============================
2. Reason for the notification
================================================================
a. Position/status Chief Operating Officer
=============================== ===============================
b. Initial notification Initial notification
/Amendment
=============================== ===============================
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
================================================================
a. Name Circassia Pharmaceuticals plc
=============================== ===============================
b. LEI 2138006YAT138TOGA556
=============================== ===============================
4. Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
================================================================
a. Description of Ordinary Shares of 0.08p each
the
Financial instrument,
type of instrument GB00BJVD3B28
Identification
code
=============================== ===============================
b. Nature of the Purchase of Ordinary Shares
transaction
=============================== ===============================
c. Price(s) and Price(s) Volume(s)
volume(s) 16.5147p 300,000
----------
=============================== ===============================
d. Aggregated information
* Aggregated volume
n/a
* Price
=============================== ===============================
e. Date of the transaction 2019-09-30
=============================== ===============================
f. Place of the London Stock Exchange, AIM
transaction
=============================== ===============================
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHBGBDGGDGBGCB
(END) Dow Jones Newswires
October 01, 2019 06:25 ET (10:25 GMT)
Circassia (LSE:CIR)
Historical Stock Chart
From Apr 2024 to May 2024
Circassia (LSE:CIR)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Circassia Group Plc (London Stock Exchange): 0 recent articles
More Circassia Pharmaceuticals Plc News Articles